These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31422386)

  • 61. Limited immune tolerance induced by transient mixed chimerism.
    Yu JH; Chung BH; Oh EJ; Kim JI; Kim HJ; Moon IS; Yang CW
    Korean J Intern Med; 2015 Sep; 30(5):735-8. PubMed ID: 26354070
    [No Abstract]   [Full Text] [Related]  

  • 62. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
    He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
    Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recent Progress in Cell Therapy in Solid Organ Transplantation.
    Garakani R; Saidi RF
    Int J Organ Transplant Med; 2017; 8(3):125-131. PubMed ID: 28924460
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The potential of mesenchymal stem cells to induce immune tolerance to allogeneic transplants.
    Yu S; Lu J
    Transpl Immunol; 2023 Dec; 81():101939. PubMed ID: 37866668
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunosuppressive treatment options in renal transplantation.
    Ciancio G; Burke GW; Jorge D; Rosen A; Miller J
    Minerva Urol Nefrol; 2005 Sep; 57(3):141-9. PubMed ID: 15986013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
    Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
    Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sirolimus after kidney transplantation.
    Sharif A
    BMJ; 2014 Nov; 349():g6808. PubMed ID: 25424845
    [No Abstract]   [Full Text] [Related]  

  • 70. Review of combined liver and kidney transplantation in children.
    Ganschow R; Hoppe B
    Pediatr Transplant; 2015 Dec; 19(8):820-6. PubMed ID: 26354144
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alemtuzumab induction in pediatric kidney transplantation.
    Nguyen C; Shapiro R
    Pediatr Transplant; 2013 Jun; 17(4):319-20. PubMed ID: 23581963
    [No Abstract]   [Full Text] [Related]  

  • 73. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia.
    Hara Y; Stolk M; Ringe J; Dehne T; Ladhoff J; Kotsch K; Reutzel-Selke A; Reinke P; Volk HD; Seifert M
    Transpl Int; 2011 Nov; 24(11):1112-23. PubMed ID: 21880071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications.
    Lipinski MJ; Luger D; Epstein SE
    Handb Exp Pharmacol; 2017; 243():329-353. PubMed ID: 28382469
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Kidney Transplant Program at the Mayo Clinic in Arizona.
    Heilman RL; Khamash HA; Huskey JL; Chakkera HA; Batra RK; Katariya NN; Singer AL; Mathur AK; Moss AA; Reddy KS
    Clin Transpl; 2014; ():61-8. PubMed ID: 26281128
    [TBL] [Abstract][Full Text] [Related]  

  • 77. More questions than answers: Current limitations of kidney transplantation treatment.
    Spechtl P; Oberbauer R
    Eur J Clin Invest; 2021 May; 51(5):e13513. PubMed ID: 33577079
    [No Abstract]   [Full Text] [Related]  

  • 78. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 79. Cross-over kidney transplantation with simultaneous laparoscopic living donor nephrectomy: initial experience.
    Giessing M; Deger S; Roigas J; Schnorr D; Fuller F; Liefeldt L; Budde K; Neumayer HH; Loening SA
    Eur Urol; 2008 May; 53(5):1074-8. PubMed ID: 17950986
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance.
    Franquesa M; Hoogduijn MJ; Baan CC
    Curr Opin Organ Transplant; 2012 Aug; 17(4):355-61. PubMed ID: 22710385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.